| SESSION NAME |
ASAM (Pharmacists, Pyschologists, Physicians, Physicians Assistants) |
ASWB (Social Worker) |
NEMSD (Nurses) |
NAADAC (Counselor) |
| SATURDAY | ASAM | ASWB | NEMSD | NAADAC |
| The Certified Medication Assistd Treatment Advocate (CMA) Training Course (Registration Required) | 0 | 8.0 | 8.0 | 8.0 |
| MAT Waiver Training | 8.5 | 8.5 | 8.5 | 8.5 |
| Romancing the Brain/Conflict Resolution in Recovery (CRR) | 0 | 7.5 | 7.5 | 7.5 |
| Confidentiality and MAT | 3.0 | 3.0 | 3.0 | 3.0 |
| Accreditation | 4.0 | 4.0 | 4.0 | 4.0 |
| Triple E for HCV Engagement Education and Eradication | 4.0 | 4.0 | 4.0 | 4.0 |
| SUNDAY | ASAM | ASWB | NEMSD | NAADAC |
| Opioid Maintenance Pharmacotherapy: A Course for Clinicians (Registration Required) | 8.0 | 8.0 | 8.0 | 8.0 |
| Long-acting Opioid Agonist Medications: Research and Clinical Practice | 4.0 | 4.0 | 4.0 | 4.0 |
| Transforming Care Delivery: High Reliability in Medication Assisted Treatment | 3.0 | 3.0 | 3.0 | 3.0 |
| Expanding Access to MAT in Correctional Settings | 3.0 | 3.0 | 3.0 | 3.0 |
| Presentations by the World Federation for the Treatment of Opioid Dependence | 4.0 | 4.0 | 4.0 | 4.0 |
| Florida Judges and Court Staff Session (Closed Session) | 4.0 | 4.0 | 4.0 | 4.0 |
| MONDAY | ASAM | ASWB | NEMSD | NAADAC |
| Poster Sessions | 1.25 | 1.25 | 1.25 | 1.25 |
| PL1: Opening Plenary Session: State of Affairs – The Opioid Epidemic | 1.5 | 1.5 | 1.5 | 1.5 |
| A1: Foundations of Medication Assisted Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| A2: The Criminal Justice System: An Effective Access Point to Treating Opioid Addiction | 1.5 | 1.5 | 1.5 | 1.5 |
| A3: Community Engagement Workshop for Opioid Treatment Programs | 1.5 | 1.5 | 1.5 | 1.5 |
| A4: Practical Methods to Increase Retention in Medication Assisted Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| A5: A Clinical Conundrum: Pain, Addiction or Both | 1.5 | 1.5 | 1.5 | 1.5 |
| #1: State Actions to Support Provider Innovation: Statutory, Regulatory and Administrative Reform | 1.5 | 1.5 | 1.5 | 1.5 |
| #2: When Disaster Strikes: Partnerships and Strategies for a Coordinated Response to Hurricane Florence | 1.5 | 1.5 | 1.5 | 1.5 |
| #3: Claims Trends and Risk Management in an Increasingly Litigious World | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: The Image of MAT and Related Stigma: Challenges and Opportunities | 0 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Using Technology to Improve Care | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Medications for Opioid Use Disorders: Which One is Best? | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Legal Cannabis in OTPs: Implications for Programs and Treatment Plans | 0 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Insurance Parity (MHPAEA) and Access: An Uncertain Present and Future | 0 | 1.5 | 1.5 | 1.5 |
| Poster Sessions | 1.0 | 1.0 | 1.0 | 1.0 |
| B1: Therapeutic Partnerships: The Most Important Evidence-Based Practice | 1.5 | 1.5 | 1.5 | 1.5 |
| B2: Connecting Community Outpatient Treatment Program to Corrections for Pregnant Patients | 1.5 | 1.5 | 1.5 | 1.5 |
| B3: Improving LGBT+ Care Through Inclusivity: A Community-Based Perspective | 1.5 | 1.5 | 1.5 | 1.5 |
| B4: Community Technical Assistance in Response to the Opioid Epidemic | 1.5 | 1.5 | 1.5 | 1.5 |
| B5: Recovery Coaching in OTPs: Making a Difference | 1.5 | 1.5 | 1.5 | 1.5 |
| TUESDAY | ASAM | ASWB | NEMSD | NAADAC |
| PL2: Middle Plenary Session: A Continuum of Care: The Criminal Justice Role in Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| C1: Assessment and Treatment for Patients with Co-Occurring Disorders | 1.5 | 1.5 | 1.5 | 1.5 |
| C2: Implementing Medication Assisted Treatment in the Justice System | 1.5 | 1.5 | 1.5 | 1.5 |
| C3: MAT in the Middle of Nowhere: Clever Solutions to a Rural Health Crisis | 1.5 | 1.5 | 1.5 | 1.5 |
| C4: Enhancing Patient Care by Avoiding Burnout and Compassion Fatigue | 1.5 | 1.5 | 1.5 | 1.5 |
| C5: Tackling Stigma Associated with SUDs | 1.5 | 1.5 | 1.5 | 1.5 |
| D1: Group Therapy for Substance Use Disorders: Basics and Beyond | 1.5 | 1.5 | 1.5 | 1.5 |
| D2: Anywhere, Anytime: A Model for Universal Access to Opioid Medication | 1.5 | 1.5 | 1.5 | 1.5 |
| D3: Racial and Ethnic Disparities in OUD: Implications for Cultural-Competence | 1.5 | 1.5 | 1.5 | 1.5 |
| D4: Managing Co-occurring Opioid Use Disorder and Chronic Pain | 1.5 | 1.5 | 1.5 | 1.5 |
| D5: Implementing Telehealth in MAT to Better Serve Rural Areas | 1.5 | 1.5 | 1.5 | 1.5 |
| The Role of Craving and Dual Disorders in Organizing Services for Heroin Addicts | 1.5 | 1.5 | 1.5 | 1.5 |
| WEDNESDAY | ASAM | ASWB | NEMSD | NAADAC |
| E1: Strengthening Trauma Informed Practices Within OTPs | 1.5 | 1.5 | 1.5 | 1.5 |
| E2: Implementing and Sustaining Enhanced MAT in Corrections: Considerations for Diversion, Recidivism and Saving Lives | 1.5 | 1.5 | 1.5 | 1.5 |
| E3: Therapeutic use of Cannabis: Facts, Myths, & Policy Considerations | 1.5 | 1.5 | 1.5 | 1.5 |
| E4: Peer Services for Medication Assisted Treatment (The MARS Project) | 1.5 | 1.5 | 1.5 | 1.5 |
| E5: Resistance or Resilience: Mind and Body Responses | 1.5 | 1.5 | 1.5 | 1.5 |
| F1:Shattering the Stigma and Shedding the Shame | 1.5 | 1.5 | 1.5 | 1.5 |
| F2: Naloxone Distribution in the Opioid Treatment Program Setting | 1.5 | 1.5 | 1.5 | 1.5 |
| F3: Breaking All Barriers: Increasing Access to Care through the Country’s First 24/7 OTP | 1.5 | 1.5 | 1.5 | 1.5 |
| F4: Unleash The Power of Parents & Peers: Engaging & Empowering Families | 1.5 | 1.5 | 1.5 | 1.5 |
| F5: Using Technology to Empower Families and Concerned Others to Support Loved Ones with Opioid Use Disorder | 1.5 | 1.5 | 1.5 | 1.5 |
| PL3: Closing Plenary Session: Combating the Opioid Epidemic as a Nation and around the World | 1.5 | 1.5 | 1.5 | 1.5 |
On behalf of the AATOD Conference Management Team, we are excited to share that the online Exhibitor and Sponsor Portal for the 2025 AATOD Conference, taking place October 4–8, 2025, in Philadelphia, is now open.
You can now purchase exhibit booths, select sponsorship opportunities, and register badges directly through the portal. You can also learn more about exhibitor opportunities and benefits on our website.
bit.ly/44rrRB6
#aatod2025
#theevolvingfieldoftreatment
1 week ago
Statement for the Record
We are sharing AATOD's latest statement that corrects misleading testimony before the Senate Select Committee on Aging.
Get the details ➡️bit.ly/3DmpAvT⬅️
2 months ago
⏰THE CLOCK IS TICKING!
Please submit your proposals by tonight’s deadline - 3/4/25 at 11:59 PM EST.
SUBMIT ➡️ www.aatodconference.com
#aatod2025
#theevolvingfieldofopioidtreatment
3 months ago
⏰ TIME IS TICKING
The Call for Presentations Submission deadline is TOMORROW, March 4th.
Submit Presentation ➡️ aatodconference.com
This conference video message places a spotlight on AATOD's 2025 Workshop Committee Co-Chairs, Robert C. Lambert, MA, LADC & Allegra Schorr, MS. View their message and gain insight on what can be expected from the robust workshop lineup that is underway ➡️
https://bit.ly/3XpYwTa.
3 months ago
NEW Call for Presentations Submission Deadline: Tues, March 4, 2025
This week's video message places a spotlight on AATOD's 2025 Conference Chair, Joshua Nirella, MSOL. Click below to view as he formally invites each of you to attend this year's conference event, and calls for your personal involvement by submitting an abstract for a workshop or poster presentation.
https://youtu.be/EkSxR5j5GxI?si=ZSZvvzYHq1rVMBi3
#aatod2025
#theevolvingfieldofopioidtreatment
3 months ago
We are still accepting workshop proposals for the world’s premier training conference event for the treatment of Opioid Use Disorder.
#aatod2025
#TheEvolvingFieldofOpioidTreatment
Complete submission by this Tuesday, 3/4 ➡️ www.aatodconference.com
✍️ We need your help and expertise to achieve our conference goals.
1️⃣ Evaluate the rapidly changing nature and the severity of the opioid epidemic and associated outcomes and develop recommendations to improve the delivery of care in various populations based on evidence-based practices.
2️⃣ Interpret emerging trends and regulatory and policy changes to determine their effects on clinical practice.
3️⃣ Discuss peer support and peer-run programs in treating opioid use disorder to improve patient outcomes.
4️⃣ Review current evidence addressing the opioid epidemic and its implications for patients, clinicians, administrators, and policy makers by identifying the most effective interventions.
5️⃣ Disseminate innovative approaches, referral pathways, and partnerships designed to treat emerging needs of patients with opioid use disorder, address pivotal issues in health, and improve patient outcomes by providing examples of effective methods and how to implement them.
3 months ago
Newsflash!
Call for Presentations EXTENDED Submission Deadline:
📆 Tuesday, March 4, 2025
📣 We are pleased to announce that the deadline for submitting presentations has been extended to Tuesday, March 4, 2025. We encourage all interested parties to take advantage of this opportunity and submit proposals as soon as possible. We look forward to receiving your proposals and to seeing you in Philadelphia this October.
To submit a proposal, please visit our conference website,https://lnkd.in/e-Xr9vQv, and follow the on-screen instructions.
For questions or additional information, please send an email to info@aatod.org or call 856-423-3091.
#aatod2025
#theevolvingfieldofopioidtreatment
3 months ago
View the first of a series of #aatod2025 Conference videos which will feature messages from our Conference Committee Chairs throughout the conference planning stages and leading up to the AATOD Conference. This week's video message spotlights AATOD's President, Mark W. Parrino, MPA, as he highlights the significance of the conference theme and provides an update on the progress of our conference planning.
💻 bit.ly/3Q4HB4s
Call for Presentations Submission Deadline: February 25, 2025�
The world's premier training conference event for the treatment of Opioid Use Disorder.
#aatod2025
#TheEvolvingFieldofOpioidTreatment
3 months ago
📣 A Call for Presentations
#aatod2025
#TheEvolvingFieldofOpioidTreatment.
💻 To submit a proposal, please visit our conference website, aatodconference.com and follow the on-screen instructions.
✍️ We are encouraging a broad number of topics for submission in order to provide a rich learning content cutting across multiple disciplines to advance the work of our field. We expect nothing less than to continue to provide the most cutting edge information at the conference. Please join leading experts in the field and consider submitting a proposal highlighting your expertise in research or in the provision of care.
📅 Submission Deadline: Tuesday, February 25, 2025
4 months ago
We’re Excited to Present the Official
AATOD Conference Announcement - #aatod2025 #theevolvingfieldofopioidtreatment
#savethedate
For more details ➡️aatodconference.com⬅️
4 months ago
We are excited to share that the online Exhibitor and Sponsor Portal for the #aatod2025 Conference. #theevolvingfieldoftreatment
You can now purchase exhibit booths, select sponsorship opportunities, and register badges directly through the portal ➡️http://bit.ly/44rrRB6.
The Evolving Field of Opioid Treatment
AATOD proudly presents the world’s premier training conference event for the treatment of Opioid Use Disorder.
Early Registration Deadline: June 30, 2025
Visit www.aatodconference.com
#aatod2025 Conference Countdown
